Tagged with Association,

Korea Sean Kim, senior director at the Korea Research-Based Pharma Industry Association (KRPIA) gives his assessment of the role of MNCs within the pharma industry in South Korea.   At the moment the main concern is that Korean prices are too low Could you provide our readers with an introduction to…

France In an exclusive interview, Yves L’Epine, president of G5 Santé and CEO of Guerbet, offers his insider take on the business climate in French healthcare and the potential for France to reclaim its position as a global industry power.   Our members are committed to finding the “healthcare integrated solutions…

Turkey Şekib Avdagiç, president of the Istanbul Chamber of Commerce and Istanbul Convention and Visitors Bureau (ICVB) provides an in-depth analysis of the ICVB’s services, the main trends shaping the city’s congress sector and the importance of the healthcare and life sciences industry to Istanbul’s corporate tourism.   Turkey is gifted…

China Steven Lynch, managing director of the British Chamber of Commerce in China, introduces the Chamber’s activities in support of their members, the research they are undertaking to produce a position paper on UK PLC in China in 2019 and the great opportunities for British businesses in China.   Brexit does…

China The Honorable William Zarit, Chairman of the American Chamber of Commerce in Beijing (AmCham Beijing), shares the insights gained over his 25 years in China, the key priorities of AmCham Beijing regarding trade and economic linkages, and the fundamental need for both countries to strike a new ‘grand bargain’ based…

France Catherine Bourrienne-Bautista, Déléguée générale of the GEMME (L’association Genérique Même Medicament, France’s generics and biosimilars association), provides her take on the state of the generics and biosimilars industry in France. Bourrienne-Bautista offers her thoughts on the 8th edition of the Strategic Council of Health Industries (CSIS) and outlines a plan…

Malaysia Billy Urudra, president of the Malaysian Organisation of Pharmaceutical Industries, highlights the major trends and challenges in the Malaysian pharmaceutical industry, especially for generics players and touches upon the potential changes that will arise from the new government.   Can you provide our readers with an overview of the current…

France Philippe Lamoureux, director of LEEM, the pharmaceutical industry’s association in France, reflects on the winds of change in the sector after the establishment of the Macron government, the 2018 Strategic Council of Health Industries (CSIS) and new pro-industry measures. I believe that we can make France a worldwide leader in…

Malaysia Dr. Saunthari Somasundaram walks us through the NCSM’s mission to raise awareness on cancer prevention and early diagnosis in Malaysia. She details the need for more government support to make cancer education a pillar in healthcare and discredits the idea that care only includes treatment and cure.   Could you…

France Dr. Denis Comet, President of AFCRO (the French Association of CROs), talks about the evolution of the clinical research environment in France and the new government actions aimed at speeding up the clinical trial process.   Didier Genot from France Biotech told us that France has lost competitiveness when it…

Hong Kong Wolfgang Niedermark of GIC in Hong Kong, part of the AHK network of German Chambers of Commerce worldwide assesses the business relationship between Germany and Asia and how Hong Kong compares to its regional competitors as an investment destination What is your assessment of the business relationship between Germany and…

Algeria Marko Ackermann of the German-Algerian Chamber of Commerce and Industry (AHK) discusses bringing German and Algerian companies together in partnerships, the investment landscape in Algeria, and the opportunities present in the country’s healthcare and life sciences sectors.   How would you describe the capabilities and offering of AHK in Algeria?…